Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, MKS INC insiders sold a net $25.0M of stock across 100 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Jun 1, 2026.
The trade is 1.6% of the 18,845 shares held after it.
2 other insiders sold within 30 days.
460 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Mora Elizabeth sold about $75.3K of MKSI under a 10b5-1 plan on Sep 1, 2026; 2 other insiders sold within 30 days and 460 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on May 22, 2026.
The trade is 7.4% of the 134,776 shares held after it.
2 other insiders sold within 30 days.
460 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Lee John Tseng-Chung sold about $3.0M of MKSI on Aug 14, 2026; 2 other insiders sold within 30 days and 460 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Feb 20, 2026.
The trade is 11.2% of the 4,097 shares held after it.
2 other insiders sold within 30 days.
460 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & GM, PSD Williams John Edward sold about $131.8K of MKSI on Aug 3, 2026; 2 other insiders sold within 30 days and 460 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Jun 10, 2026.
The trade is 4.2% of the 19,418 shares held after it.
9 other insiders sold within 30 days.
460 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & COO Schreiner James Alan sold about $281.3K of MKSI on Jun 12, 2026; 9 other insiders sold within 30 days and 460 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Jun 10, 2026.
The trade is 12.2% of the 20,230 shares held after it.
9 other insiders sold within 30 days.
460 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & COO Schreiner James Alan sold about $853.8K of MKSI on Jun 12, 2026; 9 other insiders sold within 30 days and 460 funds added in the latest 13F quarter.
100 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
MKSI planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Mora Elizabeth
Filed 2026-09-01
$75.3K
Lee John Tseng-Chung
Filed 2026-08-14
$3.0M
Williams John Edward
Filed 2026-08-03
$131.8K
MKSI mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
ICON HEALTH AND INFORMATION TECHNOLOGY FUND
$8.0M position · as of 2026-06-30
8.2%
Spear Alpha ETF
$19.8M position · as of 2026-06-30
6.8%
Archer Stock Fund
$1.3M position · as of 2026-05-31
5.0%
Royce Premier Fund
$51.9M position · as of 2026-06-30
4.5%
Invesco V.I. American Value Fund
$20.1M position · as of 2026-06-30
4.2%
Marsico Midcap Growth Focus Fund
$39.2M position · as of 2026-06-30
4.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$13.0M
$25.0M
$2.8M
+10%
+105%
2024
$8.8M
$7.4M
$2.0M
-28%
+42%
2023
$7.9M
$13.2M
$2.1M
-30%
+22%
2022
$8.1M
$3.5M
$2.0M
-43%
+1%
2021
$7.6M
$11.4M
$2.3M
+16%
+29%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $25.0M sold by insiders over 180 days, 460 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $3.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$4.3B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MKSI
FY Dec 2025
$3.9B
FY Dec 2024
$3.6B
FY Dec 2023
$3.6B
FY Dec 2022
$3.5B
FY Dec 2021
$3.0B
Jun 2026
$1.2B
Mar 2026
$1.1B
Dec 2025
$1.0B
Sep 2025
$988.0M
Jun 2025
$973.0M
Mar 2025
$936.0M
Dec 2024
$934.0M
Sep 2024
$896.0M
At each fiscal year end
Single quarter
Net margin, TTM
+10.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MKSI
FY Dec 2025
+7.5%
FY Dec 2024
n/a
FY Dec 2023
-50.8%
FY Dec 2022
+9.4%
FY Dec 2021
+18.6%
Jun 2026
+14.0%
Mar 2026
+7.8%
Dec 2025
+10.4%
Sep 2025
+7.5%
Jun 2025
+6.4%
Mar 2025
+5.6%
Dec 2024
+9.7%
Sep 2024
+6.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
$455.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MKSI
FY Dec 2025
$497.0M
FY Dec 2024
$410.0M
FY Dec 2023
$232.0M
FY Dec 2022
$365.0M
FY Dec 2021
n/a
Jun 2026
$189.0M
Mar 2026
$28.0M
Dec 2025
$92.0M
Sep 2025
$146.0M
Jun 2025
$136.0M
Mar 2025
$123.0M
Dec 2024
$125.0M
Sep 2024
$141.0M
At each fiscal year end
Single quarter
Debt to equity
1.32x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity MKSI
FY Dec 2025
1.55x
FY Dec 2024
1.95x
FY Dec 2023
2.04x
FY Dec 2022
1.16x
FY Dec 2021
0.29x
Jun 2026
1.32x
Mar 2026
1.44x
Dec 2025
1.55x
Sep 2025
1.66x
Jun 2025
1.73x
Mar 2025
1.89x
Dec 2024
1.95x
Sep 2024
2.01x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.16x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt MKSI
FY Dec 2025
0.15x
FY Dec 2024
0.12x
FY Dec 2023
0.06x
FY Dec 2022
0.10x
FY Dec 2021
0.77x
Jun 2026
0.16x
Mar 2026
0.14x
Dec 2025
0.15x
Sep 2025
0.16x
Jun 2025
0.15x
Mar 2025
0.14x
Dec 2024
0.12x
Sep 2024
0.11x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+15.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MKSI
FY Dec 2025
+11.7%
FY Dec 2024
n/a
FY Dec 2023
-52.9%
FY Dec 2022
+9.0%
FY Dec 2021
+21.0%
Jun 2026
+15.9%
Mar 2026
+12.7%
Dec 2025
+11.7%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+1.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+5.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MKSI
FY Dec 2025
+3.4%
FY Dec 2024
n/a
FY Dec 2023
-17.9%
FY Dec 2022
+4.2%
FY Dec 2021
+13.0%
Jun 2026
+5.0%
Mar 2026
+3.8%
Dec 2025
+3.4%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+0.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+9.8%
operating income after a 9.8% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital MKSI
FY Dec 2025
+8.1%
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
+5.6%
FY Dec 2021
+18.9%
Jun 2026
+9.8%
Mar 2026
+8.6%
Dec 2025
+8.1%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+9.4%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed MKSI
FY Dec 2025
+6.7%
FY Dec 2024
+6.2%
FY Dec 2023
-16.5%
FY Dec 2022
+8.4%
FY Dec 2021
+18.4%
Jun 2026
+9.4%
Mar 2026
+8.0%
Dec 2025
+6.7%
Sep 2025
+6.4%
Jun 2025
+6.3%
Mar 2025
+6.3%
Dec 2024
+6.2%
Sep 2024
+4.7%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
32.21x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MKSI
FY Dec 2025
36.48x
FY Dec 2024
37.15x
FY Dec 2023
n/a
FY Dec 2022
14.86x
FY Dec 2021
17.59x
Jun 2026
70.83x
Mar 2026
47.98x
Dec 2025
36.48x
Sep 2025
29.97x
Jun 2025
25.15x
Mar 2025
23.85x
Dec 2024
37.15x
Sep 2024
236.33x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$17.2B
market value at close 2026-10-26 on 2026-07-28 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value MKSI
FY Dec 2025
$14.5B
FY Dec 2024
$11.1B
FY Dec 2023
$11.4B
FY Dec 2022
$10.5B
FY Dec 2021
$10.1B
Jun 2026
$33.5B
Mar 2026
$19.0B
Dec 2025
$14.5B
Sep 2025
$12.2B
Jun 2025
$10.6B
Mar 2025
$9.5B
Dec 2024
$11.1B
Sep 2024
$11.7B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.3%
TTM free cash flow over market value at close 2026-10-26
FCF yield MKSI
FY Dec 2025
+4.6%
FY Dec 2024
+5.8%
FY Dec 2023
+3.4%
FY Dec 2022
+6.5%
FY Dec 2021
n/a
Jun 2026
+1.5%
Mar 2026
+2.6%
Dec 2025
+4.6%
Sep 2025
+6.4%
Jun 2025
+7.9%
Mar 2025
+9.0%
Dec 2024
+5.8%
Sep 2024
+5.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.55x
P/E over trailing EPS growth of 59%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MKSI
FY Dec 2025
0.65x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.31x
Jun 2026
1.20x
Mar 2026
1.13x
Dec 2025
0.65x
Sep 2025
0.04x
Jun 2025
0.01x
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MKSI ranks highest on institutional and government (71st percentile) and growth (67th), and lowest on insider conviction (6th), among Industrials peers.
Profitability
58
Inputs
Return on equity+15.9% · 70 pct, sector of 198
Return on assets+5.0% · 57 pct, sector of 224
Return on invested capital+9.8% · 43 pct, sector of 107
Return on capital employed+9.4% · 60 pct, sector of 195
Financial health
21
Inputs
Debt to equity1.32x · 10 pct, sector of 215
Cash flow to debt0.16x · 32 pct, sector of 173
Growth
67
Inputs
Revenue growth, YoY+9.6% · 67 pct, sector of 255
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
6
Inputs
Net Form 4 buying (codes P and S), 180d-$24.9M · 12 pct, sector of 171
Insider buyers, 180d0 · 0 pct, sector of 173
Institutional and government
71
Inputs
Funds adding, latest quarter460 · 85 pct, sector of 200
Congress net buyers, 365d0 · 57 pct, sector of 43
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
53
Inputs
Short interest, % of float+7.3% · 27 pct, sector of 271
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 192
New text in Risk Factors, latest 10-K+17.0% · 32 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MKSI filings, in plain words
Are MKS insiders buying or selling MKSI?
In the 180 days to 2026-10-28, MKS insiders were net sellers, a net $25.0M across purchases and sales reported on Form 4, by 13 sellers.
Have members of Congress traded MKSI?
Yes. In the year to 2026-10-28, 1 House member disclosed buying MKSI and 1 House member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31.
Are there planned insider sales of MKSI?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $3.2M of stock; the latest, by Mora Elizabeth, was filed 2026-09-01.
Read the full summary
In the 180 days to 2026-10-28, MKS insiders were net sellers of MKSI, a net $25.0M across purchases and sales reported on Form 4 by 13 sellers. 4% of the 26 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 1 member of Congress disclosed buying MKSI and 1 member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $3.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.